Automated patch clamp technology offers a high-throughput, accessible alternative to conventional patch clamping for ion channel research and drug screening.
Answers are grounded in this paper and cite their sources.
May expand ion channel research access; leaves open translation to cardiovascular therapeutic development.
Efficient high resolution techniques are required for screening efforts and research targeting ion channels. The conventional patch clamp technique, a high resolution but low efficiency technique, has been established for 25 years. Recent advances have opened up new possibilities for automated patch clamping. This new technology meets the need of drug developers for higher throughput and facilitates new experimental approaches in ion channel research. Specifically, Nanion's electrophysiology workstations, the Port-a-Patch and the Patchliner, have been successfully introduced as high-quality automated patch clamp platforms for industry as well as academic users. Both platforms give high quality patch clamp recordings, capable of true giga-seals and stable recordings, accessible to the user without the need for years of practical training. They also offer sophisticated experimental possibilities, such as accurate and fast ligand application, temperature control and internal solution exchange. This article describes the chip-based patch clamp technology and its usefulness in ion channel drug screening and academic research.
No takes yet. Share an insight, caveat, or question.
Farre et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: